obesity drug news today glp-1 oct 27 2025 Market Overview: Agonists and the Market | Blog GLP-1 drugs like Ozempic and

These findings reinforce the peptides relevance for studies of insulin resistance, beta-cell dynamics, and the broader mechanisms underlying metabolic disease progression

Here are expert-backed guidelines to help ensure every injection is both safe and effective

The FDA reportedly followed up with the company before finalizing its decision

Timeline and Expectations Understanding realistic timelines helps set appropriate expectations and prevents premature discontinuation before therapeutic effects fully develop

Part 1: the disease and its risk factors

Obesity is also established as the leading factor in the development of type-2 diabetes